Zenith Drugs Stock Performance
|
|
|
Zenith Drugs Company background
Founded in: 2000
Managing director: Sandeep Bhardwaj
Zenith Drugs Ltd was originally incorporated on November 15, 2000 as a Private Limited Company in the name of Zenith Drugs Private Limited issued by the Registrar of Companies, in the State of Madhya Pradesh, Gwalior. Subsequently, Company was converted into Public Limited and consequently, the name of Company was changed to Zenith Drugs Limited pursuance to issuance of a Fresh Certificate of Incorporation on September 13, 2023 by the Registrar of Companies, Gwalior. Zenith are a reputable pharmaceutical manufacturing and trading unit based out from Indore. With a diverse portfolio of formulations, the Company is specialized in manufacturing affordable and high quality medicines to meet the needs of patients. The Company is mainly engaged in the business of manufacturing and Trading of Medicines. It offers a wide range of formulations in various forms such as: ORS Powder Liquid Orals Oinments Liquid Externals and Capsules. The Company was established in 2000 by the visionary founders, Late Shri Ramniklal Soni, and Mr. Mukesh Jain. Initially in 2001, Company started as a modest manufacturing house for oral and external formulations. However, recognizing the importance of quality and compliance, the Company swiftly shifted to a Schedule M GMP compliant unit in 2004 where it started the production of two lines which are liquid orals and ointments. In 2007, it expanded the product line by incorporating ORS Powder manufacturing into their operations. In 2016, the Company established present manufacturing facility, which holds WHO GMP certification. In 2019, it expanded the product line by introducing liquid externals and capsules. The Company propose Initial Public Fresh Issue upto 42,92,000 Equity Shares.
Zenith Drugs Share Price Today
As of 10 Nov 2025, Zenith Drugs share price is ₹61.4. The stock opened at ₹61 and had closed at ₹63.2 the previous day. During today’s trading session, Zenith Drugs share price moved between ₹60.00 and ₹63.60, with an average price for the day of ₹61.80. Over the last 52 weeks, the stock has recorded a low of ₹47.15 and a high of ₹110.00. In terms of performance, Zenith Drugs share price has declined by 20.3% over the past six months and has declined by 0% over the last year.
Zenith Drugs Fundamental
Market Cap (in crs)
108.29
Face Value
10
Turnover (in lacs)
12.27
Key Metrics
Qtr Change %
44.18% Fall from 52W High
-3.9
Dividend yield 1yr %
0
Zenith Drugs Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
61.35
Current Price
Day EMA5
62.80
Day EMA10
63.10
Day EMA12
63.20
Day EMA20
63.60
Day EMA26
64.00
Day EMA50
65.40
Day EMA100
68.00
Day EMA200
71.90
Day SMA5
62.80
Day SMA10
63.40
Day SMA20
63.50
Day SMA30
64.10
Day SMA50
65.90
Day SMA100
67.70
Day SMA150
71.60
Day SMA200
72.50
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 24000 Rs | 36800 Rs |
Week Rs | 14400 Rs | 20266 Rs |
Month Rs | 9221 Rs | 11031 Rs |
Resistance & Support
61.10
Pivot
Resistance
First Resistance
65.20
Second Resistance
67.25
Third Resistance
71.35
Support
First Support
59.05
Second support
54.95
Third Support
52.90
Relative Strength Index
48.14
Money Flow Index
44.63
MACD
-0.79
MACD Signal
-0.86
Average True Range
3.18
Average Directional Index
13.29
Rate of Change (21)
-0.63
Rate of Change (125)
-22.99
Zenith Drugs Peer comparison
Compare
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
179.25 | 114.37 | 170 | 303 | 183.50 | -9.15% | -18.89% | -24.84% | -27.05% | 132.64% | 0.00% | 163.84 | 40.16 | 2.66 | |
860.00 | 106.68 | 736 | 1016 | 889.00 | 1.21% | -5.18% | 1.29% | -12.15% | 48.29% | 0.39% | 28.29 | 40.16 | 1.99 | |
98.07 | 121.48 | 81.01 | 348.45 | 98.73 | -3.59% | -5.20% | 0.28% | -66.41% | -45.07% | 0.00% | 8.59 | 40.16 | 1.23 | |
50.00 | 97.24 | 48.61 | 104.9 | 48.61 | -7.41% | -8.26% | -36.80% | 0.00% | 0.00% | 0.00% | 9.07 | 40.16 | 1.40 | |
152.75 | 99.81 | 80.8 | 152.75 | 145.50 | 14.08% | 70.12% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00 | 40.16 | 4.99 | |
Curis Lifesciences Ltd. | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zenith Drugs Share Price FAQs
How has Zenith Drugs shares performed in the past ?
Zenith Drugs share price in the past 1-year return was -43.68. The Zenith Drugs share hit a 1-year low of Rs. 47.15 and a 1-year high of Rs. 110.
What is the market cap of Zenith Drugs ?
The market cap of Zenith Drugs is Rs. 108.29 Cr. as of 10/11/2025.
What is the current P/E ratio of Zenith Drugs ?
The PE ratios of Zenith Drugs is 14.82 as of 10/11/2025.
What is the current PB ratio of Zenith Drugs ?
The PB ratios of Zenith Drugs is 1.56 as of 10/11/2025
How to buy Zenith Drugs shares?
You can easily buy Zenith Drugs shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
What is the 52-week high and low of Zenith Drugs ?
The 52-week high and low of Zenith Drugs share price is ₹110 and ₹47.15 as of 10/11/2025.
Please be aware that Zenith Drugs stock prices are subject to continuous fluctuations due to various factors.
Invest in Zenith Drugs